![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 2, 883-886, January 11, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
§
From the The neurofibromatosis type 2 tumor
suppressor gene, NF2, is mutated in the germ line of NF2
patients and predisposes affected individuals to intracranial and
spinal tumors. Moreover, somatic mutations of NF2 can occur
in the sporadic counterparts of these neurological tumor types as well
as in certain neoplasms of non-neuroectodermal origin, such as
malignant mesothelioma and melanoma. NF2 encodes a
595-amino acid protein, merlin, which exhibits significant homology to
the ezrin-radixin-moesin family of proteins. However, the mechanism by
which merlin exerts its tumor suppressor activity is not well understood. In this investigation, we show that merlin is
phosphorylated in response to expression of activated Rac and activated
Cdc42 in mammalian cells. Furthermore, we demonstrate that merlin
phosphorylation is mediated by p21-activated kinase (Pak), a
common downstream target of both Rac and Cdc42. Both in
vivo and in vitro kinase assays demonstrated that Pak
can directly phosphorylate merlin at serine 518, a site that affects
merlin activity and localization. These biochemical investigations
provide insights into the regulation of merlin function and
establish a framework for elucidating tumorigenic mechanisms involved
in neoplasms associated with merlin inactivation.
Human Genetics Program and
§ Tumor Cell Biology Program, Fox Chase Cancer Center,
Philadelphia, Pennsylvania 19111
To whom correspondence should be addressed: Fox Chase Cancer
Center, Human Genetics Program, 7701 Burholme Ave., Philadelphia, PA
19111. E-mail: JR_Testa@fccc.edu.
This article has been cited by other articles:
![]() |
C. O. Hanemann Magic but treatable? Tumours due to loss of Merlin Brain, March 1, 2008; 131(3): 606 - 615. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Muranen, M. Gronholm, A. Lampin, D. Lallemand, F. Zhao, M. Giovannini, and O. Carpen The tumor suppressor merlin interacts with microtubules and modulates Schwann cell microtubule cytoskeleton Hum. Mol. Genet., July 15, 2007; 16(14): 1742 - 1751. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. E. E. Rennefahrt, S. W. Deacon, S. A. Parker, K. Devarajan, A. Beeser, J. Chernoff, S. Knapp, B. E. Turk, and J. R. Peterson Specificity Profiling of Pak Kinases Allows Identification of Novel Phosphorylation Sites J. Biol. Chem., May 25, 2007; 282(21): 15667 - 15678. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Lee, D. Kim, H. C. Dan, E. L. Wu, T. M. Gritsko, C. Cao, S. V. Nicosia, E. A. Golemis, W. Liu, D. Coppola, et al. Identification and Characterization of Putative Tumor Suppressor NGB, a GTP-Binding Protein That Interacts with the Neurofibromatosis 2 Protein Mol. Cell. Biol., March 15, 2007; 27(6): 2103 - 2119. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Morrison, T. Sperka, J. Manent, M. Giovannini, H. Ponta, and P. Herrlich Merlin/Neurofibromatosis Type 2 Suppresses Growth by Inhibiting the Activation of Ras and Rac Cancer Res., January 15, 2007; 67(2): 520 - 527. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Hughes and R. G. Fehon Phosphorylation and activity of the tumor suppressor Merlin and the ERM protein Moesin are coordinately regulated by the Slik kinase J. Cell Biol., October 23, 2006; 175(2): 305 - 313. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Wei, V. K. Arora, A. Raney, L. S. Kuo, G.-H. Xiao, E. O'Neill, J. R. Testa, J. L. Foster, and J. V. Garcia Activation of p21-Activated Kinase 2 by Human Immunodeficiency Virus Type 1 Nef Induces Merlin Phosphorylation J. Virol., December 1, 2005; 79(23): 14976 - 14980. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Okada, M. Lopez-Lago, and F. G. Giancotti Merlin/NF-2 mediates contact inhibition of growth by suppressing recruitment of Rac to the plasma membrane J. Cell Biol., October 24, 2005; 171(2): 361 - 371. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. I. McClatchey and M. Giovannini Membrane organization and tumorigenesis--the NF2 tumor suppressor, Merlin Genes & Dev., October 1, 2005; 19(19): 2265 - 2277. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jeon, S. Kim, E. Kim, J. E. Lee, S. J. Kim, Y.-S. Juhnn, Y. S. Kim, C.-D. Bae, and J. Park Chloride Conductance Is Required for the Protein Kinase A and Rac1-dependent Phosphorylation of Moesin at Thr-558 by KCl in PC12 Cells J. Biol. Chem., April 1, 2005; 280(13): 12181 - 12189. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Rangwala, F. Banine, J.-P. Borg, and L. S. Sherman Erbin Regulates Mitogen-activated Protein (MAP) Kinase Activation and MAP Kinase-dependent Interactions between Merlin and Adherens Junction Protein Complexes in Schwann Cells J. Biol. Chem., March 25, 2005; 280(12): 11790 - 11797. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-H. Xiao, R. Gallagher, J. Shetler, K. Skele, D. A. Altomare, R. G. Pestell, S. Jhanwar, and J. R. Testa The NF2 Tumor Suppressor Gene Product, Merlin, Inhibits Cell Proliferation and Cell Cycle Progression by Repressing Cyclin D1 Expression Mol. Cell. Biol., March 15, 2005; 25(6): 2384 - 2394. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Rong, X. Tang, D. H. Gutmann, and K. Ye Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L PNAS, December 28, 2004; 101(52): 18200 - 18205. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. M. Jaffer and J. Chernoff The Cross-Rho'ds of Cell-Cell Adhesion J. Biol. Chem., August 20, 2004; 279(34): 35123 - 35126. [Full Text] [PDF] |
||||
![]() |
H.J. Spence, Y.-J. Chen, C.L. Batchelor, J.R. Higginson, H. Suila, O. Carpen, and S.J. Winder Ezrin-dependent regulation of the actin cytoskeleton by {beta}-dystroglycan Hum. Mol. Genet., August 1, 2004; 13(15): 1657 - 1668. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Alfthan, L. Heiska, M. Gronholm, G. H. Renkema, and O. Carpen Cyclic AMP-dependent Protein Kinase Phosphorylates Merlin at Serine 518 Independently of p21-activated Kinase and Promotes Merlin-Ezrin Heterodimerization J. Biol. Chem., April 30, 2004; 279(18): 18559 - 18566. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Warren, L A James, R T Ramsden, A Wallace, M E Baser, J M Varley, and D G Evans Identification of recurrent regions of chromosome loss and gain in vestibular schwannomas using comparative genomic hybridisation J. Med. Genet., November 1, 2003; 40(11): 802 - 806. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gronholm, L. Vossebein, C. R. Carlson, J. Kuja-Panula, T. Teesalu, K. Alfthan, A. Vaheri, H. Rauvala, F. W. Herberg, K. Tasken, et al. Merlin Links to the cAMP Neuronal Signaling Pathway by Anchoring the RI{beta} Subunit of Protein Kinase A J. Biol. Chem., October 17, 2003; 278(42): 41167 - 41172. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kaempchen, K. Mielke, T. Utermark, S. Langmesser, and C. O. Hanemann Upregulation of the Rac1/JNK signaling pathway in primary human schwannoma cells Hum. Mol. Genet., June 1, 2003; 12(11): 1211 - 1221. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Struckhoff and E. A. Lundquist The actin-binding protein UNC-115 is an effector of Rac signaling during axon pathfinding in C. elegans Development, February 15, 2003; 130(4): 693 - 704. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-X. Sun, C. Haipek, D. R. Scoles, S. M. Pulst, M. Giovannini, M. Komada, and D. H. Gutmann Functional analysis of the relationship between the neurofibromatosis 2 tumor suppressor and its binding partner, hepatocyte growth factor-regulated tyrosine kinase substrate Hum. Mol. Genet., December 1, 2002; 11(25): 3167 - 3178. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Scoles, V. D. Nguyen, Y. Qin, C.-X. Sun, H. Morrison, D. H. Gutmann, and S.-M. Pulst Neurofibromatosis 2 (NF2) tumor suppressor schwannomin and its interacting protein HRS regulate STAT signaling Hum. Mol. Genet., December 1, 2002; 11(25): 3179 - 3189. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-X. Sun, V. A. Robb, and D. H. Gutmann Protein 4.1 tumor suppressors: getting a FERM grip on growth regulation J. Cell Sci., January 11, 2002; 115(21): 3991 - 4000. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |